Published in J Parasitol on October 01, 1981
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it? Int J Parasitol Drugs Drug Resist (2012) 1.20
Visceral leishmaniasis: experimental models for drug discovery. Indian J Med Res (2011) 1.12
The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis. Bull World Health Organ (1992) 0.77
Role of land-surface changes in arctic summer warming. Science (2005) 5.54
Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci U S A (1978) 1.82
Testing of drugs for antileishmanial activity in golden hamsters infected with Leishmania donovani. Int J Parasitol (1977) 1.56
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster. Exp Parasitol (1983) 1.34
Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries. J Appl Physiol (1985) (1987) 1.33
The antileishmanial activity of lepidines. Am J Trop Med Hyg (1978) 1.30
Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother (1986) 1.22
Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci (1978) 1.19
Susceptibility of five strains of mice to Babesia microti of human origin. J Parasitol (1979) 1.12
Trypanosoma cruzi: effects of anti-thymocyte serum in mice and neonatal thymectomy in rats. Exp Parasitol (1973) 1.07
Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother (1990) 1.06
Thymus dependence of resistance to infection with Babesia microti of human origin in mice. Am J Trop Med Hyg (1980) 1.03
Correspondence: Transfer of immunity to T. cruzi. Trans R Soc Trop Med Hyg (1974) 1.03
Nutritional iron status and susceptibility to Proteus mirabilis pyelonephritis in the rat. Can J Microbiol (1982) 1.02
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob Agents Chemother (1992) 1.01
Influence of acetohydroxamic acid on experimental Corynebacterium renale pyelonephritis. Can J Microbiol (1977) 0.98
Neutrophil kinetics in the pulmonary microcirculation during acute inflammation. Lab Invest (1991) 0.96
Cholelithiasis in dogs. J Am Vet Med Assoc (1973) 0.95
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus). Ann Trop Med Parasitol (1985) 0.95
Hematotropic parasites of translocated raccoons in the southeast. J Am Vet Med Assoc (1978) 0.95
The fine structure of the thymus of the fetal and neonatal monkey (Macaca mulatta). Z Zellforsch Mikrosk Anat (1971) 0.94
Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci (1980) 0.92
Density of parasites in various organs and the relation to numbers of trypomastigotes in the blood during acute infections of Trypanosoma cruzi in mice. J Protozool (1974) 0.91
Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: antiprotozoal effects of some amidine types. Exp Parasitol (1981) 0.91
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. Am J Vet Res (1984) 0.90
Amyloidosis in rhesus monkeys with rheumatoid arthritis and enterocolitis. J Am Vet Med Assoc (1977) 0.90
Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. Antimicrob Agents Chemother (1990) 0.90
Comparison of the effects of neonatal thymectomy on plasmodium berghei, trypanosoma lewisi and trypanosoma cruzi infection in the albino rat. Z Parasitenkd (1974) 0.88
Influence of iron on Corynebacterium renale-induced pyelonephritis in a rat experimental model. Infect Immun (1978) 0.88
alpha-Difluoromethylornithine: a promising lead for preventive chemotherapy for coccidiosis. Am J Vet Res (1982) 0.88
CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke (1997) 0.88
Neutrophil kinetics in the pulmonary microcirculation. Effects of pressure and flow in the dependent lung. Am Rev Respir Dis (1990) 0.88
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway. Z Parasitenkd (1983) 0.88
Transfer of immunity to Babesia microti of human origin using T lymphocytes in mice. Cell Immunol (1980) 0.87
Congestive cardiomyopathy in Doberman pinscher dogs. J Am Vet Med Assoc (1982) 0.86
Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs. Am J Vet Res (1984) 0.86
Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters. J Parasitol (1991) 0.85
Course of infection of Leishmania donovani in hamsters inoculated by the intraperitoneal route. J Parasitol (1967) 0.85
Activity of purine analogs against Leishmania donovani in vivo. Antimicrob Agents Chemother (1987) 0.85
Immunization of mice with irradiated Trypanosoma cruzi growth in cell culture: relation of numbers of parasites, immunizing injections, and route of immunization to resistance. Int J Parasitol (1976) 0.84
The effects of total-body x-irradiation on Trypanosoma cruzi infection (Chagas' disease) in mice and rats. Z Parasitenkd (1973) 0.84
Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters. Ann Trop Med Parasitol (1984) 0.84
In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model. J Med Chem (1977) 0.84
Abomasal adenocarcinoma in a cow. J Am Vet Med Assoc (1982) 0.83
Experimental Rat model for Corynebacterium renale-induced pyelonephritis. Infect Immun (1977) 0.82
Determination of virulence and pathogenesis of a canine strain of Leishmania leishmania infantum in hamsters and dogs. Am J Vet Res (1993) 0.82
Potent, long-acting bradykinin antagonists for a wide range of applications. Can J Physiol Pharmacol (1997) 0.82
Antileishmanial activity of selected compounds in dogs experimentally infected with Leishmania donovani. Rev Inst Med Trop Sao Paulo (1980) 0.82
Leishmania braziliensis: effects of bacteria (Staphylococcus aureus and Pasteurella multocida) on the developing cutaneous leishmaniasis lesion in the golden hamster. Exp Parasitol (1983) 0.81
Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages. Infect Immun (1979) 0.81
Activity of anticancer compounds against Trypanosoma cruzi-infected mice. Am J Trop Med Hyg (1998) 0.81
Appearance of ossification centers and epiphysial closures as determined by radiographic techniques. J Am Vet Med Assoc (1965) 0.80
Chemotherapy and the immune response in protozoal infections. J Protozool (1981) 0.80
Trypanosoma cruzi: morphogenesis in diffusion chambers in the mouse peritoneal cavity and attempted stimulation of host immunity. Exp Parasitol (1974) 0.80
Primaquine analogues that are potent anti-Trypanosoma cruzi agents in a mouse model. Ann Trop Med Parasitol (1996) 0.80
Trypanosoma cruzi: the T-cell dependence of the primary immune response and the effects of depletion of T cells and Ig-bearing cells on immunological memory. Cell Immunol (1980) 0.80
Leishmania donovani in the owl monkey (aotus trivirgatus) Trans R Soc Trop Med Hyg (1981) 0.79
Pulmonary microcirculatory kinetics of neutrophils deficient in leukocyte adhesion-promoting glycoproteins. J Appl Physiol (1985) (1990) 0.79
Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus). J Parasitol (1983) 0.79
Occurrence of antibody to Trypanosoma cruzi in dogs in the southeastern United States. Am J Vet Res (1981) 0.79
Evidence that certain 8-aminoquinolines are potentially effective drugs against Chagas disease. Ann Trop Med Parasitol (1997) 0.79
Experimental infection of Triatoma infestans and Rhodnius prolixus with Trypanosomatidae of the genera Crithidia and Blastocrithidia. J Protozool (1968) 0.79
Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum. Lab Anim Sci (1993) 0.78
Immunoglobulin levels in a laboratory-acquired case of human Chagas' disease. J Parasitol (1974) 0.78
Brugia pahangi: histopathological study of golden hamsters. Exp Parasitol (1976) 0.78
Leishmania donovani: clinical, hematologic and hepatic changes in squirrel monkeys (Saimiri sciureus). J Parasitol (1985) 0.78
Heterologous and specific immunization of mice against Trypanosoma cruzi. J Parasitol (1980) 0.78
Leishmania donovani in the oppossum (Didelphis marsupialis). J Parasitol (1980) 0.78
Studies on the enzymes of Sarcocystis suicanis: purification and characterization of an acid phosphatase. J Parasitol (1987) 0.78
Acid hydrolases of the coccidian Eimeria tenella. Experientia (1983) 0.77
Intramuscular Sarcocystis sp. in two cats and a dog. J Parasitol (1988) 0.77
Experimental visceral leishmaniasis in the owl monkey. Vet Pathol (1986) 0.77
In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model. Proc Soc Exp Biol Med (1997) 0.77
Flow through zone 1 lungs utilizes alveolar corner vessels. J Appl Physiol (1985) (1991) 0.77
Isolation of Acanthamoeba sp. from a greyhound with pneumonia and granulomatous amebic encephalitis. J Vet Diagn Invest (1993) 0.77